Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sensus Healthcare (SRTS) Return on Sales (2016 - 2025)

Sensus Healthcare has reported Return on Sales over the past 10 years, most recently at 0.64% for Q4 2025.

  • Quarterly results put Return on Sales at 0.64% for Q4 2025, down 76.0% from a year ago — trailing twelve months through Dec 2025 was 0.28% (down 44.0% YoY), and the annual figure for FY2025 was 0.28%, down 44.0%.
  • Return on Sales for Q4 2025 was 0.64% at Sensus Healthcare, down from 0.14% in the prior quarter.
  • Over the last five years, Return on Sales for SRTS hit a ceiling of 1.55% in Q1 2022 and a floor of 0.64% in Q4 2025.
  • Median Return on Sales over the past 5 years was 0.08% (2021), compared with a mean of 0.05%.
  • Biggest five-year swings in Return on Sales: soared 212bps in 2021 and later plummeted -211bps in 2023.
  • Sensus Healthcare's Return on Sales stood at 0.41% in 2021, then crashed by -47bps to 0.22% in 2022, then surged by 55bps to 0.34% in 2023, then plummeted by -65bps to 0.12% in 2024, then tumbled by -642bps to 0.64% in 2025.
  • The last three reported values for Return on Sales were 0.64% (Q4 2025), 0.14% (Q3 2025), and 0.14% (Q2 2025) per Business Quant data.